Stryker® Orthopaedics Hip Implant Recall
Stryker® Orthopaedics recalled its Rejuvenate modular and ABG II modular stem and neck hip implants. The Food and Drug Administration (FDA) posted the recall on its website after the hip implants were pulled from the market. According to Stryker, fretting and corrosion is occurring with some hip implant devices, causing potentially serious conditions such as metallosis and/or necrosis (tissue death. The side effects are commonly referred to as Adverse Local Tissue Reactions, or "ALTR." Pain, swelling, hypersensitivity, allergic reactions and osteolysis(bone damage) were reported in some cases involving Stryker Rejuvenate or ABG II implants. Complications caused by implanted Stryker Rejuvenate or ABG II hip implant devices can lead to revision surgery or repeated doctor visits.
Stryker Hip Recall Model Information
Stryker Orthopaedics manufactures numerous medical implant devices. The devices targeted by the July 6, 2012 recall are the:
- Rejuvenate Modular Hip System
- ABG II Modular Stems and ABG II Necks
If you don’t know the model of the hip implant you received, you may call my office for a free consultation and we can help you obtain that information.
Hip Implants and Serious Health Risks
If you are a hip implant patient and you experience pain or swelling in the area of the hip replacements, you should contact your surgeon immediately. While all hip implant complications may not be outwardly visible, adverse side effects such as pain or swelling may indicate a complication. Unfortunately, revision surgery is sometimes necessary to correct health issues related to the recalled device.
If you or someone you know received a recalled Stryker Orthopaedics hip implant and suffered serious side effects, contact me to find out if you may quality for compensation. I also represent individuals who suffered injuries caused by DePuy ASR and DePuy Pinnacle hip implants. Call (859-525-1900) or fill out the Priority Consult form.
Stryker® is a registered trademark of Stryker Corporation. This law firm is not associated with, sponsored by, or affiliated with the U.S. Food and Drug Administration or Stryker Corporation.
